Answers are grounded in this paper and cite their sources.
Background: Pulmonary embolism (PE) in young, otherwise healthy patients is an uncommon diagnosis that can be easily missed due to its non-specific clinical presentation. Case Presentation: A 20-year-old woman presented to the emergency department with acute-onset chest pain, dyspnoea, palpitations, dizziness, and diaphoresis of 8 hours duration. Her only identifiable risk factor was the recent initiation of a combined oral contraceptive pill (OCP, Femilon) three months prior. On examination, she was tachycardic (145/min) and tachypnoeic (24/min) but maintained a normal blood pressure (102/76 mmHg) and room air oxygen saturation (99%). An electrocardiogram revealed sinus tachycardia with an S1Q3T3 pattern and incomplete right bundle branch block. Point-of-care echocardiography demonstrated marked right heart dilatation, reduced tricuspid annular plane systolic excursion (TAPSE), and McConnell's sign. Troponin I was elevated. CT pulmonary angiography confirmed an extensive bilateral pulmonary thrombus extending into segmental and interlobar arteries. She was successfully managed with systemic thrombolysis (streptokinase 1.5 million IU) and low-molecular-weight heparin, later transitioning to oral apixaban, and was discharged after a 3-day hospital stay. Conclusion: Clinicians must maintain a high index of suspicion for PE in young women taking oral contraceptives who present with unexplained chest pain or tachycardia. Early integration of bedside echocardiography and ECG is crucial for timely diagnosis and management.
No takes yet. Share an insight, caveat, or question.
Shankar et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: